Healthcare Global Enterprises

500.00
-6.85
(-1.35%)
Market Cap
6,970.14 Cr
EPS
3.46
PE Ratio
127.06
Dividend Yield
0.00 %
52 Week High
567.70
52 Week low
314.00
PB Ratio
8.18
Debt to Equity
1.29
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy75.00 %
75.00 %
Hold25.00 %
25.00 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
989.75 96,216.77 90.16 5,584.10 18.77 1,058 -17.46 44.30
6,143.75 88,337.70 67.40 19,165.50 14.74 917 49.14 35.55
615.55 46,471.45 59.77 6,931.20 8.99 645 89.49 45.78
1,573.20 32,150.04 41.29 5,093.40 10.96 790 2.66 63.74
1,168.30 31,379.06 62.04 2,759.20 25.09 326 15.71 50.94
549.70 21,995.64 60.61 2,511.20 12.94 336 20.76 48.60
431.75 21,566.48 82.67 3,723.70 22.85 205 -69.22 49.88
1,242.15 12,614.24 53.35 1,334.00 10.76 218 10.06 36.65
1,501.50 9,844.74 51.73 1,095.50 21.32 177 20.14 49.43
500.00 6,970.14 127.06 1,929.10 12.97 41 129.41 47.87
Growth Rate
Revenue Growth
12.97 %
Net Income Growth
134.66 %
Cash Flow Change
13.11 %
ROE
135.47 %
ROCE
5.76 %
EBITDA Margin (Avg.)
-1.64 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
133
142
143
143
156
170
176
178
186
194
219
212
229
228
248
250
261
270
279
279
271
195
251
279
302
326
495
360
367
410
421
428
446
463
489
475
502
534
564
563
Expenses
115
123
127
125
131
144
149
150
153
162
180
180
191
198
213
222
231
228
238
234
236
176
218
245
343
272
292
342
302
336
345
349
365
386
402
391
403
435
451
470
EBITDA
19
19
17
18
25
26
28
28
34
32
39
32
38
30
34
28
30
43
42
45
35
19
33
34
-41
55
202
18
65
74
76
78
80
76
87
84
100
99
112
93
Operating Profit %
13 %
13 %
11 %
12 %
15 %
14 %
15 %
15 %
16 %
15 %
15 %
13 %
14 %
13 %
13 %
11 %
10 %
15 %
14 %
15 %
12 %
8 %
12 %
10 %
-16 %
16 %
17 %
4 %
17 %
18 %
18 %
18 %
17 %
16 %
17 %
17 %
18 %
17 %
18 %
16 %
Depreciation
10
11
11
11
12
13
14
15
15
15
17
18
21
20
21
22
23
34
35
38
42
39
40
42
38
38
38
41
41
40
41
41
42
41
43
44
46
47
50
57
Interest
9
9
9
10
11
5
6
5
7
7
10
10
15
18
24
13
16
31
35
36
36
37
27
29
26
26
23
24
24
25
26
27
26
26
27
30
27
34
36
41
Profit Before Tax
0
0
-1
-1
2
8
8
8
12
10
12
4
2
-8
-10
-7
-8
-23
-27
-28
-42
-57
-32
-35
-104
-9
142
-46
1
10
10
11
13
11
18
11
28
19
28
-3
Tax
0
-0
-1
1
-2
3
3
3
4
4
2
2
2
-1
-3
-1
3
-2
-2
1
9
-11
-5
-1
9
4
43
4
-1
8
5
7
8
7
7
8
5
5
7
-11
Net Profit
0
1
-1
-2
4
5
5
5
8
6
10
1
-0
-6
-8
-6
-11
-21
-25
-29
-50
-46
-27
-35
-114
-13
99
-50
2
3
5
4
6
4
11
3
24
14
21
8
EPS in ₹
-0.04
-0.07
-0.23
-0.30
0.44
0.59
0.58
0.63
0.90
0.55
1.17
0.37
0.30
-0.39
-0.74
-0.71
-0.99
-2.05
-2.51
-2.57
-4.91
-4.48
-1.94
-2.33
-8.14
-0.76
8.22
-3.55
0.43
0.44
0.53
0.54
0.60
0.55
0.97
0.41
1.53
0.87
1.29
0.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Fixed Assets
529
568
685
828
970
1,646
1,382
1,547
1,553
1,758
Current Assets
122
201
244
220
273
304
435
502
580
680
Capital Work in Progress
42
155
148
174
153
46
30
22
18
83
Investments
0
60
11
53
49
34
26
9
10
10
Other Assets
205
252
382
389
482
527
597
642
735
856
Total Liabilities
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Current Liabilities
187
195
366
359
547
576
465
470
570
744
Non Current Liabilities
284
270
371
506
584
1,258
856
866
876
1,099
Total Equity
305
569
490
579
522
420
714
884
869
865
Reserve & Surplus
209
451
347
398
389
293
528
731
721
687
Share Capital
70
85
86
87
88
89
125
139
139
139

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
85
-29
-24
-56
-30
62
190
-22
-5
Investing Activities
-79
-204
-210
-283
-238
-101
-171
125
-133
-226
Operating Activities
60
73
91
98
99
130
121
220
252
285
Financing Activities
22
216
89
161
84
-58
112
-155
-140
-64

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
70.71 %
68.41 %
68.40 %
71.44 %
71.43 %
71.42 %
71.39 %
71.38 %
71.37 %
71.35 %
71.30 %
71.29 %
71.28 %
71.25 %
71.23 %
71.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.28 %
0.00 %
6.74 %
3.95 %
4.29 %
2.77 %
DIIs
7.82 %
7.86 %
6.27 %
5.52 %
4.90 %
3.56 %
4.03 %
4.40 %
5.54 %
6.58 %
7.94 %
6.66 %
8.52 %
10.89 %
11.64 %
12.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.05 %
9.46 %
10.83 %
10.07 %
10.84 %
11.58 %
11.21 %
11.60 %
11.44 %
10.43 %
9.96 %
9.68 %
9.39 %
9.41 %
9.33 %
9.60 %
Others
14.42 %
14.26 %
14.50 %
12.97 %
12.83 %
13.44 %
13.38 %
12.61 %
11.65 %
11.63 %
4.52 %
12.37 %
4.07 %
4.49 %
3.50 %
3.46 %
No of Share Holders
13,891
15,065
20,573
22,362
23,663
23,018
24,672
28,707
28,858
25,931
27,327
27,289
27,195
26,529
29,670
32,820

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Open Offer - Updates
1 day ago
Draft Letter of Offer
1 day ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
6 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations
9 days ago
Detailed Public Statement
9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 27, 2025, 12:36
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 27, 2025, 12:36
Disclosure under Regulation 30A of LODR
Feb 25, 2025, 12:26
Disclosure under Regulation 30A of LODR
Feb 25, 2025, 12:26
Integrated Filing (Financial)
Feb 24, 2025, 18:56
Public Announcement - Open Offer
Feb 24, 2025, 08:25
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Feb 23, 2025, 23:22
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Feb 23, 2025, 23:22
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Feb 23, 2025, 23:07
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Feb 23, 2025, 23:07
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 23, 2025, 22:00
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 23, 2025, 22:00
Announcement Under Regulation 30
Feb 23, 2025, 21:22
Announcement Under Regulation 30
Feb 23, 2025, 21:22
Announcement Under Regulation 30
Feb 23, 2025, 21:15
Announcement Under Regulation 30
Feb 23, 2025, 21:15
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Feb 23, 2025, 20:59
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Feb 23, 2025, 20:59
Board Meeting Outcome for Disclosure Under Regulation 30
Feb 23, 2025, 20:38
Board Meeting Outcome for Disclosure Under Regulation 30
Feb 23, 2025, 20:38
Announcment Under Regulation 30- Rescheduling Of Earnings Call
Feb 19, 2025, 18:48
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 17, 2025, 11:28
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 16, 2025, 18:06
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 16, 2025, 17:59
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 15, 2025, 18:32
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Feb 14, 2025, 14:23
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Feb 14, 2025, 13:12
Results- Financial Results For Decembe 31 2024
Feb 14, 2025, 13:04
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 11, 2025, 21:10
Update on board meeting
Feb 11, 2025, 20:48
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 07, 2025, 19:46
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 06, 2025, 17:01
Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises Limited
Feb 05, 2025, 18:26
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 15, 2025, 16:50
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 10, 2025, 18:09
Closure of Trading Window
Dec 30, 2024, 15:54
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dec 09, 2024, 15:47
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 19, 2024, 12:49
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 13, 2024, 14:08
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 11, 2024, 16:01
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 11, 2024, 15:50
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 09, 2024, 20:39
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 09, 2024, 20:15
Announcement under Regulation 30 (LODR)-Resignation of Director
Nov 09, 2024, 18:45
Intimation Regarding Execution Of Business Transfer Agreement ('BTA') By Healthcare Global Enterprises Limited ('The Company Or 'The Buyer') For The Acquisition Of Oncology Business Located At Nagpur, From HCG NCHRI Oncology LLP, Its Wholly Owned Subsidiary.
Nov 09, 2024, 18:34

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
51.02
ATR(14)
Less Volatile
19.24
STOCH(9,6)
Neutral
54.32
STOCH RSI(14)
Neutral
67.35
MACD(12,26)
Bullish
0.29
ADX(14)
Weak Trend
11.85
UO(9)
Bearish
55.08
ROC(12)
Uptrend And Accelerating
1.42
WillR(14)
Neutral
-48.83